Trial intelligence / Profile preview

Magnesium sulfate for PONV in laparoscopic gynecologic surgery

NCT03541915Unknown

Sponsor
Gangnam Severance Hospital
Start
Dec 2018
Primary completion
May 2019
Modality
Small Molecules
01

Overview

Randomised, double-blind trial of magnesium sulfate in postoperative nausea and vomiting (PONV), sponsored by Gangnam Severance Hospital. Primary endpoint: Incidence of Postoperative Nausea and Vomiting at 2 days. Status: unknown.

02

Drugs

magnesium sulfate
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT03541915.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03541915.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call